Origin of Adenocarcinoma in Barrett's Esophagus: P53 and Ki67 Expression and Histopathologic Background

Clinics - Brazil
doi 10.1590/s1807-59322005000200005
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

Expression of Bile Acid Transporting Proteins in Barrett's Esophagus and Esophageal Adenocarcinoma

American Journal of Gastroenterology
HepatologyGastroenterology
2009English

MicroRNAs in Barrett's Esophagus and Esophageal Adenocarcinoma

Current Opinion in Pharmacology
Drug DiscoveryPharmacology
2009English

P53 - Prognostic Factor of Malignant Transformation of Barrett's Esophagus

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2005English

GATA6 Expression in Barrett's Oesophagus and Oesophageal Adenocarcinoma

Digestive and Liver Disease
HepatologyGastroenterology
2015English

Patient Preferences for the Chemoprevention of Esophageal Adenocarcinoma in Barrett's Esophagus

American Journal of Gastroenterology
HepatologyGastroenterology
2008English

Endoscopic Submucosal Dissection of a Minute Intramucosal Adenocarcinoma in Barrett's Esophagus

Digestive Endoscopy
Nuclear MedicineRadiologyImagingGastroenterology
2009English

Association Between Markers of Obesity and Progression From Barrett's Esophagus to Esophageal Adenocarcinoma

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2013English

Barrett's Esophagus: Diagnosis and Management

Gastrointestinal Endoscopy
Nuclear MedicineRadiologyImagingGastroenterology
2017English

Increased Expression and Secretion of Interleukin-6 in Patients With Barrett's Esophagus

Clinical Cancer Research
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy